Tumor vaccine study for brain surgery patients
Part of Cancer clinical trials.
This study tests whether a tumor vaccine made from your own surgery tissue can help treat solid tumors, specifically gliomas (brain tumors). It is open to patients having brain surgery at Huashan Hospital, including those with non-tumor conditions like stroke or injury, as long as enough tissue is available.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are scheduled for brain surgery at Huashan Hospital and are diagnosed with either a glioma (a type of brain tumor) or a non-tumor condition like hemorrhagic stroke, ischemic stroke, or traumatic brain injury.
- During surgery, a tissue sample of at least 6 mm × 6 mm must be available for the study after the routine diagnosis is done.
- You must sign an informed consent form to take part in the study.
- You cannot be currently enrolled in any other clinical trial.
- If you are female, you must not be pregnant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at a protein called B7-H4 to help create a potential vaccine for glioma (a type of brain tumor). It uses a small tissue sample taken during your surgery to check if the vaccine might work for you.
This study looks at how brain tumors look on MRI and what biopsy tissue shows, using samples taken during planned surgery. It may help improve understanding of tumor biology and future treatment planning.
This trial tests a personalized vaccine made from your own cells to help your immune system attack tumor-specific targets. It may be an option if standard treatments have stopped working or caused side effects you can't tolerate.
This early-stage study tests a personalized cancer vaccine designed to prevent glioblastoma (a serious brain tumor) from coming back after surgery and standard treatment. The vaccine aims to train your immune system to recognize and attack any remaining cancer cells.
This study looks at how your immune system reacts to brain tumor surgery and standard treatment, using a special dye to help the surgeon see the tumor better. It aims to find out if this approach can improve outcomes for people with glioblastoma.
This trial studies a gene-based treatment (HSV-tk) given with radiation and chemotherapy for people newly diagnosed with glioblastoma or anaplastic astrocytoma. It may help the new brain tumor respond better to standard treatments, though risks and benefits are still being tested.
Hear when a new Glioma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.